---
schema_version: "secwatch.filing_event.v1"
accession: "0001790340-25-000063"
form_type: "8-K"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:42:59.718018+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immuneering annual meeting: all three director nominees elected, auditor ratified

## Summary
- 69.1% of outstanding Class A common stock represented at June 13, 2025 meeting.
- Ann E. Berman, Diana F. Hausman, M.D., and Thomas J. Schall, Ph.D. elected as Class I directors.
- RSM US LLP ratified as independent auditor for fiscal year ending December 31, 2025.
- Broker non-votes of 10,009,639 on director elections; no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0001790340-25-000063
- form_type: 8-K
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/0001790340-25-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/imrx-20250613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001790340-25-000063
- JSON: https://secwatch.observer/filing/0001790340-25-000063.json
- Plain text: https://secwatch.observer/filing/0001790340-25-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.